Intimation about Schedule of Analyst / Institutional Investor Meeting on June 5, 2026
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Neuland Laboratories Limited has filed an intimation with NSE and BSE informing about a scheduled group analyst/institutional investor meeting on June 5, 2026. The meeting is part of a BOFA (Bank of America) Healthcare Tour and will be held in Hyderabad. The company notes that the schedule and participant list is subject to change due to exigencies. This is a routine regulatory disclosure under SEBI LODR Regulation 30 governing investor communication norms.
This is a standard investor relations disclosure with no direct impact on stock price. Such participation in organized healthcare sector tours by major banks may indicate active institutional investor engagement.